Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2015, Article ID 690891, 5 pages
http://dx.doi.org/10.1155/2015/690891
Case Report

Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination

1Department of Pathology, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
2Department of Diagnostic Pathology, Miyazaki University Hospital, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
3Department of Gynecology and Obstetrics, Koga Hospital, 1749-1 Sudaki, Ikeuchi, Miyazaki 880-0041, Japan

Received 27 February 2015; Revised 27 April 2015; Accepted 27 April 2015

Academic Editor: Anna Fagotti

Copyright © 2015 Eriko Nakamura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Rutgers and R. E. Scully, “Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of Mullerian type. A clinicopathologic analysis,” Cancer, vol. 61, no. 3, pp. 546–554, 1988. View at Publisher · View at Google Scholar · View at Scopus
  2. H. W. Shappell, M. A. Riopel, A. E. Smith Sehdev, B. M. Ronnett, and R. J. Kurman, “Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas,” The American Journal of Surgical Pathology, vol. 26, no. 12, pp. 1529–1541, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Kurman, M. L. Carcangiu, C. S. Herrington, and R. H. Young, WHO Classification of Tumors of Female Reproductive Organs, International Agency for Research on Cancer, Lyon, France, 4th edition, 2014.
  4. V. Dubé, M. Roy, M. Plante, M.-C. Renaud, and B. Têtu, “Mucinous ovarian tumors of mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas,” International Journal of Gynecological Pathology, vol. 24, no. 2, pp. 138–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. E. D'Angelo, F. Dadmanesh, S. Pecorelli, and J. Prat, “Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (Müllerian) type,” International Journal of Gynecological Pathology, vol. 29, no. 6, pp. 529–532, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Vang, A. M. Gown, T. S. Barry, D. T. Wheeler, and B. M. Ronnett, “Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive,” International Journal of Gynecological Pathology, vol. 25, no. 1, pp. 83–89, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Dutt and D. M. Berney, “Clear cell carcinoma of the ovary arising in a mucinous cystadenoma,” Journal of Clinical Pathology, vol. 53, no. 12, pp. 938–939, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Wani and K. Notohara, “Ovarian clear cell carcinoma arising in a mucinous cystadenoma,” International Journal of Gynecological Pathology, vol. 28, no. 6, pp. 584–588, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Maeda and I.-M. Shih, “Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms,” Advances in Anatomic Pathology, vol. 20, no. 1, pp. 45–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. H. Wu, T.-L. Mao, R. Vang et al., “Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A,” International Journal of Gynecological Pathology, vol. 31, no. 4, pp. 297–303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. Bishop, R. Sharma, and P. B. Illei, “Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma,” Human Pathology, vol. 41, no. 1, pp. 20–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Fadare, M. M. Desouki, K. Gwin et al., “Frequent expression of napsin a in clear cell carcinoma of the endometrium: potential diagnostic utility,” The American Journal of Surgical Pathology, vol. 38, no. 2, pp. 189–196, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Skirnisdottir, K. Bjersand, H. Åkerud, and T. Seidal, “Napsin A as a marker of clear cell ovarian carcinoma,” BMC Cancer, vol. 13, article 524, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Mostoufizadeh and R. E. Scully, “Malignant tumors arising in endometriosis,” Clinical Obstetrics and Gynecology, vol. 23, no. 3, pp. 951–963, 1980. View at Publisher · View at Google Scholar · View at Scopus
  15. R. L. Parker, F. Dadmanesh, R. H. Young, and P. B. Clement, “Polypoid endometriosis: a clinicopathologic analysis of 24 cases and a review of the literature,” American Journal of Surgical Pathology, vol. 28, no. 3, pp. 285–297, 2004. View at Publisher · View at Google Scholar · View at Scopus